The biotechnology (biotech) industry is incredibly diverse.
Recently, I wrote about the dimensions of the biotech industry, which is, of
course, associated with how biotechnology is defined. As a strict definition,
biotechnology is that the use of biology to show raw materials into useful
products. However, the act of developing a biotech product requires many
enabling technologies, reagents, and services that form today's modern
industry.
The term biotechnology was first coined in 1919 by Károly
Erek, a Hungarian agricultural engineer, who foresaw a time when biology might
be used for turning staples into useful products. The emerging field of
synthetic biology represents the natural progression of this concept as our
ability to synthesize gene sequences and engineer biochemical pathways and even
entire microorganisms in rational designs for a myriad of purposes from specialty
chemicals, to food, to energy, improve.
While biotechnology products like bread, wine, and beer, are
around for millennia, the earliest biotechnology companies, as exemplified by
Genentech was founded within the late 1970s after the initial discoveries of
restriction enzymes and therefore the realization they might be harnessed to be
used in DNA cloning. Many of those companies focused on producing human
therapeutic proteins, like human insulin, in cost-effective ways. to hold out
this work, these companies also needed reagents like restriction enzymes that
were in themselves biotech products. Hence, an ecosystem of companies developed
into a bigger industry.
0 Comments